… range of illnesses such as haemophilia and Crohn’s disease, … start his leukaemia treatment — which is a horrible treatment — in Gaza … , the nurses, physios, ­pharmacists and occupational therapists that are … playing a part in treating children whose lives have …

… hemophilia B develop inhibitors, which makes treatment of hemophilia … Phase 2 clinical trial results, the FDA granted Breakthrough … ® Prescribing Information and Medication Guide About Novo Nordisk … untreated patients with severe haemophilia B: a PedNet study …

… those infected and affected. Haemophilia Society chief executive Kate … Those recommendations ranged from the development of a compensation scheme, … us to access care and treatment, free of charge. … ChronicleLive team. We also treat our community members to …

… children who are undergoing cancer treatment. Aflac NI brought its … for Sick Children who treat them, simply would not … ’s University Belfast to develop a learning programme focused … with sickle cell disease, haemophilia and other life-threatening blood …

… the risk of the development of hepatocellular carcinoma or … the US Food and Drug Administration (FDA) in 2025. While … III open-label expansion trial for fitusiran, a first … are still significant challenges in haemophilia treatment, large advances are being …

… that will produce medications to treat rare diseases. The new drug production plant … manufacture medications to treat rare conditions such as the blood disorder haemophilia. Novo … its popular weight-loss drug Wegovy, is developing a 200-acre site …

Digital rendering of how the new Novo Nordisk production facility in Odense, Denmark, will look (Image: Novo Nordisk) Danish pharmaceutical company Novo Nordisk is to invest DKK 8.5 billion (US$1.2 billion) in the construction of a new production facility …

… the usual treatment? The primary approach to treating haemophilia is … used to treat haemophilia B or severe haemophilia A. This … And Drug Administration-approved gene therapy for haemophilia. Called … How was the Vellore trial different? The main difference …

… central government redirecting funding for haemophilia treatment from medical colleges to district … lacks the crucial resources to treat patients affected by this genetic … equipped to handle ongoing, specialised haemophilia treatments. In response to the …

… of Medicine. Goaded by the trial results, Alok Srivastava, professor … Witwatersrand points out that this trial addresses some of the … promise as a long-term treatment for haemophilia A. It’s a … . Several diseases such as haemophilia and sickle cell anaemia are …